Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: A multicenter survey of evaluation practices and complication rates

M. Di Stasi, L. Buscarini, T. Livraghi, A. Giorgio, A. Salmi, I. De Sio, F. Brunello, L. Solmi, E. Caturelli, F. Magnolfi, M. Caremani, C. Filice

Research output: Contribution to journalArticle

Abstract

Background: Percutaneous ethanol injection (PEI) has become a widely used procedure in the treatment of hepatocellular carcinoma (HCC). However, the criteria for selecting patients are not standardized, and little information is available about the complications of the procedure. Methods: A questionnaire was sent to 11 experienced Italian centers. It investigated: the size and the number of HCC nodules suitable for treatment and the Child- Pugh risk class of the associated cirrhosis; the performance of the procedure; the number and characteristics of the patients treated; and, finally, any complications. Results: Most of the centers performed PEI in single HCC nodules less than 5 cm in diameter or in multiple nodules if fewer than three, the larger being less than 3 cm. Patients in Child-Pugh's classes A, B, and C with single nodules were generally considered for PEI. A prothrombin time of less than 40% and a platelet count of less than 40,000/mm3 contraindicated PEI in most of the centers. PEI was generally performed on outpatients, using Chiba or spinal needles. One thousand and sixty-six patients (8118 sessions) were enrolled; 74% had a single HCC nodule and 26% multiple nodules. All except four had cirrhosis; 53% were in Child class A, 38% in class B, and 9% in class C. The mean number of sessions needed to destroy an HCC nodule was 6.7 (range, 2-14), with a mean alcohol injection volume of 5.0 ml per session (range, 2-20 ml). One death (0.09%) and 34 complications (3.2%) were reported. Among the complications we call attention to the hemorrhagic ones (eight cases) and tumoral seeding (seven cases). Severe pain experienced during the maneuver led to discontinuation of the procedure in 3.7% of the patients; 13.5% of the patients required analgesics and 24% had fever after PEI. Conclusions: Some procedural aspects of PEI treatment differ among the various centers: a standardization is advisable. In the present survey PEI is a low-risk technique.

Original languageEnglish
Pages (from-to)1168-1173
Number of pages6
JournalScandinavian Journal of Gastroenterology
Volume32
Issue number11
Publication statusPublished - 1997

Fingerprint

Hepatocellular Carcinoma
Ethanol
Injections
Therapeutics
Fibrosis
Surveys and Questionnaires
Prothrombin Time
Platelet Count
Needles
Analgesics
Fever
Outpatients
Alcohols
Pain

Keywords

  • Alcohol
  • Complications
  • Interventional procedures
  • Liver
  • Liver neoplasms
  • Therapy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma : A multicenter survey of evaluation practices and complication rates. / Di Stasi, M.; Buscarini, L.; Livraghi, T.; Giorgio, A.; Salmi, A.; De Sio, I.; Brunello, F.; Solmi, L.; Caturelli, E.; Magnolfi, F.; Caremani, M.; Filice, C.

In: Scandinavian Journal of Gastroenterology, Vol. 32, No. 11, 1997, p. 1168-1173.

Research output: Contribution to journalArticle

Di Stasi, M, Buscarini, L, Livraghi, T, Giorgio, A, Salmi, A, De Sio, I, Brunello, F, Solmi, L, Caturelli, E, Magnolfi, F, Caremani, M & Filice, C 1997, 'Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: A multicenter survey of evaluation practices and complication rates', Scandinavian Journal of Gastroenterology, vol. 32, no. 11, pp. 1168-1173.
Di Stasi, M. ; Buscarini, L. ; Livraghi, T. ; Giorgio, A. ; Salmi, A. ; De Sio, I. ; Brunello, F. ; Solmi, L. ; Caturelli, E. ; Magnolfi, F. ; Caremani, M. ; Filice, C. / Percutaneous ethanol injection in the treatment of hepatocellular carcinoma : A multicenter survey of evaluation practices and complication rates. In: Scandinavian Journal of Gastroenterology. 1997 ; Vol. 32, No. 11. pp. 1168-1173.
@article{b011fd4c4fa543a0b7679e730c23dffa,
title = "Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: A multicenter survey of evaluation practices and complication rates",
abstract = "Background: Percutaneous ethanol injection (PEI) has become a widely used procedure in the treatment of hepatocellular carcinoma (HCC). However, the criteria for selecting patients are not standardized, and little information is available about the complications of the procedure. Methods: A questionnaire was sent to 11 experienced Italian centers. It investigated: the size and the number of HCC nodules suitable for treatment and the Child- Pugh risk class of the associated cirrhosis; the performance of the procedure; the number and characteristics of the patients treated; and, finally, any complications. Results: Most of the centers performed PEI in single HCC nodules less than 5 cm in diameter or in multiple nodules if fewer than three, the larger being less than 3 cm. Patients in Child-Pugh's classes A, B, and C with single nodules were generally considered for PEI. A prothrombin time of less than 40{\%} and a platelet count of less than 40,000/mm3 contraindicated PEI in most of the centers. PEI was generally performed on outpatients, using Chiba or spinal needles. One thousand and sixty-six patients (8118 sessions) were enrolled; 74{\%} had a single HCC nodule and 26{\%} multiple nodules. All except four had cirrhosis; 53{\%} were in Child class A, 38{\%} in class B, and 9{\%} in class C. The mean number of sessions needed to destroy an HCC nodule was 6.7 (range, 2-14), with a mean alcohol injection volume of 5.0 ml per session (range, 2-20 ml). One death (0.09{\%}) and 34 complications (3.2{\%}) were reported. Among the complications we call attention to the hemorrhagic ones (eight cases) and tumoral seeding (seven cases). Severe pain experienced during the maneuver led to discontinuation of the procedure in 3.7{\%} of the patients; 13.5{\%} of the patients required analgesics and 24{\%} had fever after PEI. Conclusions: Some procedural aspects of PEI treatment differ among the various centers: a standardization is advisable. In the present survey PEI is a low-risk technique.",
keywords = "Alcohol, Complications, Interventional procedures, Liver, Liver neoplasms, Therapy",
author = "{Di Stasi}, M. and L. Buscarini and T. Livraghi and A. Giorgio and A. Salmi and {De Sio}, I. and F. Brunello and L. Solmi and E. Caturelli and F. Magnolfi and M. Caremani and C. Filice",
year = "1997",
language = "English",
volume = "32",
pages = "1168--1173",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - Percutaneous ethanol injection in the treatment of hepatocellular carcinoma

T2 - A multicenter survey of evaluation practices and complication rates

AU - Di Stasi, M.

AU - Buscarini, L.

AU - Livraghi, T.

AU - Giorgio, A.

AU - Salmi, A.

AU - De Sio, I.

AU - Brunello, F.

AU - Solmi, L.

AU - Caturelli, E.

AU - Magnolfi, F.

AU - Caremani, M.

AU - Filice, C.

PY - 1997

Y1 - 1997

N2 - Background: Percutaneous ethanol injection (PEI) has become a widely used procedure in the treatment of hepatocellular carcinoma (HCC). However, the criteria for selecting patients are not standardized, and little information is available about the complications of the procedure. Methods: A questionnaire was sent to 11 experienced Italian centers. It investigated: the size and the number of HCC nodules suitable for treatment and the Child- Pugh risk class of the associated cirrhosis; the performance of the procedure; the number and characteristics of the patients treated; and, finally, any complications. Results: Most of the centers performed PEI in single HCC nodules less than 5 cm in diameter or in multiple nodules if fewer than three, the larger being less than 3 cm. Patients in Child-Pugh's classes A, B, and C with single nodules were generally considered for PEI. A prothrombin time of less than 40% and a platelet count of less than 40,000/mm3 contraindicated PEI in most of the centers. PEI was generally performed on outpatients, using Chiba or spinal needles. One thousand and sixty-six patients (8118 sessions) were enrolled; 74% had a single HCC nodule and 26% multiple nodules. All except four had cirrhosis; 53% were in Child class A, 38% in class B, and 9% in class C. The mean number of sessions needed to destroy an HCC nodule was 6.7 (range, 2-14), with a mean alcohol injection volume of 5.0 ml per session (range, 2-20 ml). One death (0.09%) and 34 complications (3.2%) were reported. Among the complications we call attention to the hemorrhagic ones (eight cases) and tumoral seeding (seven cases). Severe pain experienced during the maneuver led to discontinuation of the procedure in 3.7% of the patients; 13.5% of the patients required analgesics and 24% had fever after PEI. Conclusions: Some procedural aspects of PEI treatment differ among the various centers: a standardization is advisable. In the present survey PEI is a low-risk technique.

AB - Background: Percutaneous ethanol injection (PEI) has become a widely used procedure in the treatment of hepatocellular carcinoma (HCC). However, the criteria for selecting patients are not standardized, and little information is available about the complications of the procedure. Methods: A questionnaire was sent to 11 experienced Italian centers. It investigated: the size and the number of HCC nodules suitable for treatment and the Child- Pugh risk class of the associated cirrhosis; the performance of the procedure; the number and characteristics of the patients treated; and, finally, any complications. Results: Most of the centers performed PEI in single HCC nodules less than 5 cm in diameter or in multiple nodules if fewer than three, the larger being less than 3 cm. Patients in Child-Pugh's classes A, B, and C with single nodules were generally considered for PEI. A prothrombin time of less than 40% and a platelet count of less than 40,000/mm3 contraindicated PEI in most of the centers. PEI was generally performed on outpatients, using Chiba or spinal needles. One thousand and sixty-six patients (8118 sessions) were enrolled; 74% had a single HCC nodule and 26% multiple nodules. All except four had cirrhosis; 53% were in Child class A, 38% in class B, and 9% in class C. The mean number of sessions needed to destroy an HCC nodule was 6.7 (range, 2-14), with a mean alcohol injection volume of 5.0 ml per session (range, 2-20 ml). One death (0.09%) and 34 complications (3.2%) were reported. Among the complications we call attention to the hemorrhagic ones (eight cases) and tumoral seeding (seven cases). Severe pain experienced during the maneuver led to discontinuation of the procedure in 3.7% of the patients; 13.5% of the patients required analgesics and 24% had fever after PEI. Conclusions: Some procedural aspects of PEI treatment differ among the various centers: a standardization is advisable. In the present survey PEI is a low-risk technique.

KW - Alcohol

KW - Complications

KW - Interventional procedures

KW - Liver

KW - Liver neoplasms

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=9844259469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9844259469&partnerID=8YFLogxK

M3 - Article

C2 - 9399400

AN - SCOPUS:9844259469

VL - 32

SP - 1168

EP - 1173

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 11

ER -